Oxford StemTech

Company profile

Oxford StemTech company profile

Reprogramming is a difficult, complex process which is expensive to perform and is labour-intensive. StemTech was founded by Oxford University Researchers, who are a world leading research group in stem cell based disease models and drug discovery, to tackle these bottlenecks. StemTech has developed a new method that drastically reduces the cost and hugely increases the scale of reprogramming. Importantly our method produces the highest quality stem cell lines for research. This means that StemTech can undertake big reprogramming projects for a fraction of the cost and a fraction of time of any of its competitors. This opens new and exciting opportunities for using stem cells in drug discovery.